Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
IN8bio (INAB)
NASDAQ:INAB
IN8bio (INAB) Stock Price & Analysis
34 Followers
INAB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.02 - $3.95
Previous Close$3.15
Volume702.42K
Average Volume (3M)3.73M
Market Cap
$93.71M
Enterprise Value$88.34M
Total Cash (Recent Filing)$10.90M
Total Debt (Recent Filing)$5.53M
Price to Earnings (P/E)-2.3
Beta1.29
Next Earnings
Sep 08, 2023EPS Estimate
-$0.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.34
Shares Outstanding29,750,348
10 Day Avg. Volume365,075
30 Day Avg. Volume3,731,207
Standard Deviation0.31
R-Squared0.00271
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)13.32
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.09
Forecast
1Y Price Target
$11.33Price Target Upside315.02% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
IN8bio News
Market NewsIN8bio Soars after Promising Drug Data
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INAB FAQ
What was IN8bio’s price range in the past 12 months?
IN8bio lowest stock price was $1.02 and its highest was $3.95 in the past 12 months.
What is IN8bio’s market cap?
Currently, no data Available
When is IN8bio’s upcoming earnings report date?
IN8bio’s upcoming earnings report date is Sep 08, 2023 which is in 95 days.
How were IN8bio’s earnings last quarter?
IN8bio released its earnings results on May 12, 2023. The company reported -$0.3 earnings per share for the quarter, beating the consensus estimate of -$0.32 by $0.02.
Is IN8bio overvalued?
According to Wall Street analysts IN8bio’s price is currently Undervalued.
Does IN8bio pay dividends?
IN8bio does not currently pay dividends.
What is IN8bio’s EPS estimate?
IN8bio’s EPS estimate is -$0.27.
How many shares outstanding does IN8bio have?
IN8bio has 29,750,347 shares outstanding.
What happened to IN8bio’s price movement after its last earnings report?
IN8bio reported an EPS of -$0.3 in its last earnings report, beating expectations of -$0.32. Following the earnings report the stock price went up 7.798%.
Which hedge fund is a major shareholder of IN8bio?
Currently, no hedge funds are holding shares in INAB
---
IN8bio Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$11.33 (315.02% Upside)
$11.33 (315.02% Upside)
Crowd Wisdom
Positive
Last 7 Days ▼ 3.8%
Last 30 Days ▲ 6.9%
Last 30 Days ▲ 6.9%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
38.76%
12-Months-Change
Fundamentals
Return on Equity
-120.51%
Trailing 12-Months
Asset Growth
-32.46%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
IN8bio
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.
---
Top 5 ETFs holding INAB
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold INAB. The ETFs are listed according to market value of INAB within the ETF
---
---